How is fatty liver graded on Ultrasound (USG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Grading of Fatty Liver on Ultrasound (USG)

Fatty liver on ultrasound is graded into three categories: mild, moderate, and severe, based on specific sonographic features related to liver echogenicity and visualization of intrahepatic structures. 1

Ultrasound Grading System

Grade 1 (Mild Steatosis)

  • Mild diffuse increase in liver echogenicity
  • Clear visualization of diaphragm and intrahepatic vessel walls
  • Minimal to no attenuation of ultrasound beam 1

Grade 2 (Moderate Steatosis)

  • Moderate increase in liver echogenicity
  • Obscuration of the diaphragm
  • Partial obscuration of intrahepatic vessel walls
  • Moderate attenuation of ultrasound beam 1

Grade 3 (Severe Steatosis)

  • Marked increase in liver echogenicity
  • Non-visualization of the diaphragm
  • Non-visualization of intrahepatic vessel walls
  • Marked attenuation of ultrasound beam 1

Diagnostic Accuracy and Limitations

Ultrasound has excellent specificity (93.6%) for detecting moderate to severe steatosis (>30% fat infiltration), but significantly lower sensitivity (53.3-65%) for mild steatosis 1. This creates several important clinical considerations:

  • False negatives are common with mild steatosis - 25% of patients with histologically proven fat infiltration may have normal ultrasound findings 2
  • False positives occur frequently - echogenic abnormalities may result from fibrosis or inflammation rather than fat 2
  • Observer variability is substantial - interobserver agreement for fatty liver presence is approximately 72% (kappa = 0.43) and intraobserver agreement is about 76% (kappa = 0.54) 3

Correlation with Other Diagnostic Methods

When compared to liver biopsy (gold standard), ultrasound grading shows:

  • Good overall correlation (Spearman's correlation 0.80) 4
  • Limited accuracy for individual grade prediction - many patients with mild steatosis on ultrasound have moderate steatosis histologically 4
  • All patients with severe steatosis on histology have at least moderate-to-severe steatosis on ultrasound 4

When compared to MRI:

  • Moderate correlation between ultrasound score and MRI-determined hepatic fat fraction (r = 0.68) 4
  • High false positive rate with mild steatosis - 72% of patients with mild steatosis on ultrasound had negative MRI findings 4
  • Wide range of actual fat content in moderate steatosis - MRI-determined hepatic fat fractions ranging from 1-39% 4

Clinical Implications

  • Body Mass Index (BMI) and triglyceride levels show statistically significant associations with ultrasound grading of fatty liver 5
  • Ultrasonic elastography can provide quantitative assessment of fatty liver severity with high sensitivity (97.14%) and specificity (91.11%) 6
  • Presence of nodular liver surface, decreased right lobe-caudate lobe ratio, or signs of portal hypertension on ultrasound suggests progression to cirrhosis rather than simple steatosis 1

Pitfalls and Caveats

  1. Avoid over-reliance on ultrasound alone for diagnosis of mild steatosis due to high false negative rates
  2. Be cautious when interpreting echogenic liver in patients with chronic liver disease - abnormalities may represent fibrosis/inflammation rather than fat 2
  3. Consider the significant inter- and intra-observer variability when following patients longitudinally 3
  4. Use additional diagnostic tools (MRI, elastography, or biopsy) when accurate quantification of hepatic fat is clinically important 4, 1

References

Guideline

Liver Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.